Evidence map›Paper›PMID 30537484›Full record

ArticleOphthalmology2019

GNAQ Mutations in Diffuse and Solitary Choroidal Hemangiomas.

Jasmine H Francis, Tatyana Milman, Hans Grossniklaus, Daniel Albert, Robert Folberg, Gregory Levitin, Sarah Coupland, Federica Catalanotti, David Rabady, Cyriac Kandoth and 2 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Jasmine H FrancisMemorial Sloan-Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York. Electronic address: francij1@mskcc.org.
Tatyana MilmanDepartments of Ophthalmology and Pathology, Wills Eye Hospital and Thomas Jefferson University Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
Hans GrossniklausDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
Daniel AlbertMcPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin.
Robert FolbergOakland University William Beaumont School of Medicine, Rochester, Michigan.
Gregory LevitinNew York Eye and Ear Infirmary of Mount Sinai, New York, New York.
Sarah CouplandDepartment of Cellular and Molecular Medicine, University of Liverpool, Liverpool, United Kingdom.
Federica CatalanottiMemorial Sloan-Kettering Cancer Center, New York, New York.
David RabadyOphthalmic Consultants of the Capital Region, Albany, New York.
Cyriac KandothMemorial Sloan-Kettering Cancer Center, New York, New York.
Klaus BusamMemorial Sloan-Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York.
David AbramsonMemorial Sloan-Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York.
Memorial Sloan Kettering Cancer Center · USCornell University · USEmory University · USNew York Eye and Ear Infirmary · USOakland University · USOphthalmic Consultants of Long Island · USThomas Jefferson University Hospital · USUniversity of Liverpool · GBUniversity of Wisconsin–Madison · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeGNAQ mutations have been identified in port wine stains (both syndromic and nonsyndromic) and melanocytic ocular neoplasms. This study investigates the presence of GNAQ mutations in diffuse (those associated with Sturge-Weber syndrome [SWS]) and solitary choroidal hemangiomas.

participantsTissue from 11 patients with the following diagnoses: port wine stain (n = 3), diffuse choroidal hemangioma (n = 1), solitary choroidal hemangioma (n = 6), and choroidal nevus (n = 1).

methodsTen specimens were interrogated with Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets, a hybridization capture-based next-generation sequencing assay for targeted deep sequencing of all exons and selected introns of 468 key cancer genes in formalin-fixed, paraffin-embedded tumors. Digital polymerase chain reaction was used to detect GNAQ Q209 mutation in 1 specimen.

main outcome measuresDetection of GNAQ codon-specific mutation.

resultsActivating somatic GNAQ mutations (c.547C > T; p.Arg183Cys) were found in 100% (3 of 3) of the port wine stain and in the diffuse choroidal hemangioma. Somatic GNAQ mutations (c.626A > T; p.Gln209Leu) were found in 100% (6 of 6) of the solitary choroidal hemangiomas and (c.626A > C; p.Gln209Pro) in the choroidal nevus.

conclusionsGNAQ mutations occur in both diffuse and solitary hemangiomas, although at distinct codons. An R183 codon is mutant in diffuse choroidal hemangiomas, consistent with other Sturge-Weber vascular malformations. By contrast, solitary choroidal hemangiomas have mutations in the Q209 codon, similar to other intraocular melanocytic neoplasms.

Indexed as

MutationBiomarkers, TumorChoroidChoroid NeoplasmsDNA Mutational AnalysisDNA, NeoplasmFemaleFollow-Up StudiesGTP-Binding Protein alpha Subunits, Gq-G11HemangiomaHumansMaleRetrospective StudiesBiomarkers, TumorDNA, NeoplasmGNAQ protein, humanGTP-Binding Protein alpha Subunits, Gq-G11

Identifiers

PMID30537484
PMCPMC8425501
OpenAlexW2904840484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.